Normal brain imaging accompanies neuroimmunologically justified, autoimmune encephalomyelitis
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective To examine cases with a clinical course, signs, and symptoms mimicking MS, but without abnormalities on conventional MRI.
Methods Among 550 people with a tentative diagnosis of MS or neuromyelitis optica spectrum disorder (NMOSD), we selected patients, who met the 2010 McDonald diagnosis criteria for MS, but did not show abnormal findings on conventional brain and spinal cord MRI. After evaluating their clinical data, we analyzed fractional anisotropy (FA) values in the brain white matter on diffusion tensor MRIs and the frequencies of B-cell subsets in the peripheral blood in the corresponding cases as compared to healthy controls.
Results Eleven patients (age: 41.1 ± 8.0 years, 9 women and 2 men) met the selection criteria. They were functionally disabled, with a median expanded disability status scale score of 6.0 (2.0–8.0). CSF oligoclonal bands were negative in all cases. IV methylprednisolone and plasmapheresis (PP) were found to be efficacious. Diffusion tensor MRI analysis revealed extensive white matter abnormalities characterized by significantly decreased FA values. The frequency of plasmablasts in the peripheral blood was significantly increased in these patients similar to NMOSD.
Conclusions The neurologic disabilities in these patients could be ascribed to brain white matter damage, as revealed by MRI analysis, whereas the efficacy of PP and B-cell abnormalities in the patients suggested an autoimmune-mediated pathogenesis. In the differential diagnosis of MS, we propose that this condition be referred to as, “Normal-appearing Imaging-associated, Neuroimmunologically Justified, Autoimmune encephalomyelitis.”
Glossary
- AQP4=
- aquaporin-4;
- DTI=
- diffusion tensor image;
- EDSS=
- Expanded Disability Status Scale;
- FA=
- fractional anisotropy;
- FLAIR=
- fluid-attenuated inversion recovery;
- FOV=
- field of view;
- HC=
- healthy control;
- HTLV=
- human T-cell leukemia virus;
- IFN-β=
- interferon-β;
- IVMP=
- IV methylprednisolone;
- MOG=
- myelin oligodendrocyte glycoprotein;
- NCNP=
- National Center of Neurology and Psychiatry;
- NINJA=
- Normal-appearing Imaging-associated, Neuroimmunologically Justified, Autoimmune encephalomyelitis;
- NMOSD=
- neuromyelitis optica spectrum disorder;
- OB=
- oligoclonal band;
- PBMC=
- peripheral blood mononuclear cell;
- PP=
- plasmapheresis;
- SSEP=
- somatosensory evoked potential;
- TBSS=
- tract-based spatial statistics;
- VEP=
- visual evoked potential
Footnotes
Funding information and disclosures are provided at the end of the article. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/NN.
The Article Processing Charge was funded by the authors.
- Received September 7, 2017.
- Accepted in final form February 27, 2018.
- Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Articles
Diffusion tensor MRI changes in cerebellar structures of patients with familial essential tremorG. Nicoletti, D. Manners, F. Novellino et al.Neurology, March 22, 2010 -
Articles
Diffusion tensor MRI assesses corticospinal tract damage in ALSC.M. Ellis, A. Simmons, D.K. Jones et al.Neurology, September 01, 1999 -
Article
White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson diseaseIan O. Bledsoe, Glenn T. Stebbins, Doug Merkitch et al.Neurology, November 14, 2018 -
Articles
White matter damage on diffusion tensor imaging correlates with age-related cognitive declineR. A. Charlton, T. R. Barrick, D. J. McIntyre et al.Neurology, January 24, 2006